# Cellular-Mediated Immunity in COVID-19

> **NCT04746521** · — · UNKNOWN · sponsor: **University of Campania Luigi Vanvitelli** · enrollment: 100 (estimated)

## Conditions studied

- Covid19
- Thromboembolism

## Interventions

- **DIAGNOSTIC_TEST:** Multitest 6 color TBNK and BD Lyotubes
- **BIOLOGICAL:** genomicDNA extraction

## Key facts

- **NCT ID:** NCT04746521
- **Lead sponsor:** University of Campania Luigi Vanvitelli
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-14
- **Primary completion:** 2022-01-14
- **Final completion:** 2022-12-14
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04746521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04746521, "Cellular-Mediated Immunity in COVID-19". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04746521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*